180 related articles for article (PubMed ID: 17262714)
1. Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.
Flys TS; Donnell D; Mwatha A; Nakabiito C; Musoke P; Mmiro F; Jackson JB; Guay LA; Eshleman SH
J Infect Dis; 2007 Mar; 195(5):711-5. PubMed ID: 17262714
[TBL] [Abstract][Full Text] [Related]
2. Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
Flys TS; Mwatha A; Guay LA; Nakabiito C; Donnell D; Musoke P; Mmiro F; Jackson JB; Eshleman SH
AIDS; 2007 Oct; 21(15):2077-82. PubMed ID: 17885298
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.
Flys TS; Chen S; Jones DC; Hoover DR; Church JD; Fiscus SA; Mwatha A; Guay LA; Mmiro F; Musoke P; Kumwenda N; Taha TE; Jackson JB; Eshleman SH
J Acquir Immune Defic Syndr; 2006 Aug; 42(5):610-3. PubMed ID: 16773030
[TBL] [Abstract][Full Text] [Related]
4. Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.
Flys T; Nissley DV; Claassen CW; Jones D; Shi C; Guay LA; Musoke P; Mmiro F; Strathern JN; Jackson JB; Eshleman JR; Eshleman SH
J Infect Dis; 2005 Jul; 192(1):24-9. PubMed ID: 15942890
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
Eshleman SH; Guay LA; Mwatha A; Cunningham SP; Brown ER; Musoke P; Mmiro F; Jackson JB
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):595-9. PubMed ID: 15242535
[TBL] [Abstract][Full Text] [Related]
6. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.
Jackson JB; Becker-Pergola G; Guay LA; Musoke P; Mracna M; Fowler MG; Mofenson LM; Mirochnick M; Mmiro F; Eshleman SH
AIDS; 2000 Jul; 14(11):F111-5. PubMed ID: 10983633
[TBL] [Abstract][Full Text] [Related]
7. Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission.
Flys TS; McConnell MS; Matovu F; Church JD; Bagenda D; Khaki L; Bakaki P; Thigpen MC; Eure C; Fowler MG; Eshleman SH
J Infect Dis; 2008 Aug; 198(4):465-9. PubMed ID: 18582198
[TBL] [Abstract][Full Text] [Related]
8. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.
Johnson JA; Li JF; Morris L; Martinson N; Gray G; McIntyre J; Heneine W
J Infect Dis; 2005 Jul; 192(1):16-23. PubMed ID: 15942889
[TBL] [Abstract][Full Text] [Related]
9. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
[TBL] [Abstract][Full Text] [Related]
10. Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission.
Loubser S; Balfe P; Sherman G; Hammer S; Kuhn L; Morris L
AIDS; 2006 Apr; 20(7):995-1002. PubMed ID: 16603851
[TBL] [Abstract][Full Text] [Related]
11. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
Eshleman SH; Mracna M; Guay LA; Deseyve M; Cunningham S; Mirochnick M; Musoke P; Fleming T; Glenn Fowler M; Mofenson LM; Mmiro F; Jackson JB
AIDS; 2001 Oct; 15(15):1951-7. PubMed ID: 11600822
[TBL] [Abstract][Full Text] [Related]
12. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
13. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
Pilger D; Hauser A; Kuecherer C; Mugenyi K; Kabasinguzi R; Somogyi S; Harms G; Kunz A
Antivir Ther; 2011; 16(1):109-13. PubMed ID: 21311114
[TBL] [Abstract][Full Text] [Related]
14. Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.
Toni TD; Masquelier B; Lazaro E; Dore-Mbami M; Ba-Gomis FO; Téa-Diop Y; Kouakou K; Diby J; Sia E; Soppi S; Essien S; Schrive MH; Pinson P; Chenal H; Fleury HJ
AIDS Res Hum Retroviruses; 2005 Dec; 21(12):1031-4. PubMed ID: 16379606
[TBL] [Abstract][Full Text] [Related]
15. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.
Eshleman SH; Hoover DR; Chen S; Hudelson SE; Guay LA; Mwatha A; Fiscus SA; Mmiro F; Musoke P; Jackson JB; Kumwenda N; Taha T
J Infect Dis; 2005 Jul; 192(1):30-6. PubMed ID: 15942891
[TBL] [Abstract][Full Text] [Related]
16. Nevirapine resistance after single dose prophylaxis.
Eshleman SH; Jackson JB
AIDS Rev; 2002; 4(2):59-63. PubMed ID: 12152519
[TBL] [Abstract][Full Text] [Related]
17. HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.
Church JD; Hudelson SE; Guay LA; Chen S; Hoover DR; Parkin N; Fiscus SA; Mmiro F; Musoke P; Kumwenda N; Jackson JB; Taha TE; Eshleman SH
AIDS Res Hum Retroviruses; 2007 Jun; 23(6):764-8. PubMed ID: 17604538
[TBL] [Abstract][Full Text] [Related]
18. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
Persaud D; Bedri A; Ziemniak C; Moorthy A; Gudetta B; Abashawl A; Mengistu Y; Omer SB; Isehak A; Kumbi S; Adamu R; Lulseged S; Ashworth R; Hassen E; Ruff A;
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
van Zyl GU; Claassen M; Engelbrecht S; Laten JD; Cotton MF; Theron GB; Preiser W
J Med Virol; 2008 Jun; 80(6):942-6. PubMed ID: 18428139
[TBL] [Abstract][Full Text] [Related]
20. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
Jones D; Parkin N; Hudelson SE; Guay LA; Musoke P; Mmiro F; Jackson JB; Eshleman SH
AIDS Res Hum Retroviruses; 2005 Apr; 21(4):319-24. PubMed ID: 15943576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
